建立一个开发口服疫苗的新平台,该平台基于酵母菌子的表面显示系统
Chenyu Si1, Jiawen Bai1, Yuqing Li1
1Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122, China.
International journal of molecular sciences
|May 7, 2025
概括
这项研究介绍了一种新的口服疫苗平台,使用酵母子传递COVID-19抗原. 开发的口服疫苗表现出稳定性,并诱导强大的免疫反应,为疫苗开发提供了一个有前途的新战略.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 口服疫苗在施用和粘膜免疫方面具有优势,但在胃肠道稳定性和输送方面面临挑战.
- 开发有效的口服疫苗输送系统对于提高疫苗的可访问性和有效性至关重要.
研究的目的:
- 建立一个新的口服疫苗平台,使用表面显示的酵母子.
- 在这个平台上开发的COVID-19口服疫苗候选人的疗效.
主要方法:
- 改造了Saccharomyces cerevisiae子以显示SARS-CoV-2受体结合域 (RBD).
- 在试验室中评估了胃肠道稳定性,并在动物模型中评估了免疫反应 (幽默,粘膜,细胞).
主要成果:
- 显示的RBD显示出出色的胃肠道稳定性.
- 接种疫苗诱导了显著的幽默和粘膜免疫,具有T-辅助型1 (Th1) 倾斜的细胞反应.
- 证明了对SARS-CoV-2进行全面免疫反应的快速诱导.
结论:
- 麦芽胞 (Saccharomyces cerevisiae) 为开发稳定有效的口服疫苗提供了一个可行的平台.
- 该平台显示了快速开发口服疫苗的潜力,用于对抗各种病原体,包括SARS-CoV-2.
相关概念视频
Yeast Signaling
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...


